Adjudin

Adjudin (AF-2364), also 1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide, is an analogue of lonidamine, an indazole-carboxylic acid.

According to a May 1, 2007 news article by science writer Robert Finn in the twice-monthly newspaper "Ob.Gyn.News" about a presentation "Future Contraception: What's in the Pipeline?" by nurse-practitioner and nurse-midwife Sharon Schnare on March 8, 2007 at the Contemporary Forums Contraceptive Technology conference in San Francisco, "Adjudin is currently in phase II human trials". [cite journal | title=Male Contraceptive Methods Are in the Pipeline |author=Robert Finn |journal=Ob.Gyn. News 42:28, May 1, 2007 [http://www.obgynnews.com/article/PIIS0029743707703956/fulltext Full text] [http://download.journals.elsevierhealth.com/pdfs/journals/0029-7437/PIIS0029743707703956.pdf PDF] ]

As shown in mature male rats, the agent induces reversible germ cell loss from the seminiferous epithelium by disrupting cell adhesion function between Sertoli and germ cells. [Dolores D. Mruk and C. Yan Cheng. Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis. Endocrine Reviews (2004) 25 (5): 747-806] It weakens the adhesion between the Sertoli cell and maturing sperm leading to a sloughing and loss of the latter. [Cheng CY, Mruk D, Silvestrini B, Bonanomi M, Wong CH, Siu MK, Lee NP, Lui WY, Mo MY. AF-2364 [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide] is a potential male contraceptive: a review of recent data. Contraception. 2005 Oct;72(4):251-61. PMID 16181968] As it does not affect spermatogonia themselves the loss of fertility is reversible. In experiments hormonal levels (FSH, LH, testosterone) were undisturbed during administration, and normal spermatogenesis returned in 95% of the tubules of rats at 210 days after the drug had been discontinued. [Grima J, Silvestrini B, Cheng CY. Reversible inhibition of spermatogenesis in rats using a new male contraceptive, 1-(2,4-dichlorobenzyl)-indazole-3-carbohydrazide. Biol Reprod. 2001 May;64(5):1500-8. PMID 11319158]

When taken orally, the drug has very low bioavailability. The oral dose effective for contraception is so high that there have been side effects in the muscles and liver. Coupling an Adjudin molecule to a mutant form of follicle-stimulating hormone may solve this problem. [ [http://www.newscientist.com/article/dn10397-future-male-pill-targets-testicles.html Future male 'pill' targets testicles] New Scientist, 29 October 2006, citing Mruk DD, Wong CH, Silvestrini B, Cheng CY. A male contraceptive targeting germ cell adhesion. Nature Medicine advance access 29 October 2006 (DOI: 10.1038/nm1420)] The mutant FSH is modified such that it not longer induces Inhibin B production, but the membrane-bound FSH receptors on Sertoli cells still bind to it, delivering the Adjudin directly to the target cells.

References

External links

* [http://news.independent.co.uk/uk/health_medical/article1940823.ece "Trials for alternative male Pill show no side-effects"] at the Independent
* [http://news.bbc.co.uk/1/hi/health/6091582.stm "Sperm-stopping male pill hope"] at BBC News
* [http://www.malecontraceptives.org/methods/others.php Adjudin (a Lonidamine analogue)] at MaleContraceptives.org